Array
(
[id] => 864
[catid] => 255
[title] => Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/864.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:15
[updatetime] => 2024-01-11 15:14:15
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => The Society of Anesthesia and Sleep Medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => Patients with OSA may be at increased risk for adverse respiratory events from the use of opioid medication. (2C)
[laiyuan] => 阻塞性呼吸睡眠暂停综合征患者可能因使用阿片类药物而增加不良呼吸事件的风险（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957255
[_updatetime] => 1704957255
[_nrjc] =>
[_nrsh] =>
)
推荐意见
阻塞性呼吸睡眠暂停综合征患者可能因使用阿片类药物而增加不良呼吸事件的风险（证据级别：低；推荐强度：弱推荐）
Patients with OSA may be at increased risk for adverse respiratory events from the use of opioid medication. (2C)
证据评价方法：GRADE
指南质量等级：B
年份：2018
国家：The Society of Anesthesia and Sleep Medicine
Array
(
[id] => 865
[catid] => 264
[title] => Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/865.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:15
[updatetime] => 2024-01-11 15:14:15
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => The Society of Anesthesia and Sleep Medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => The possibility of altered pain perception in patients with OSA should be considered. (2C)
[laiyuan] => 应考虑阻塞性呼吸睡眠暂停综合征患者疼痛感知改变的可能性（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957255
[_updatetime] => 1704957255
[_nrjc] =>
[_nrsh] =>
)
推荐意见
应考虑阻塞性呼吸睡眠暂停综合征患者疼痛感知改变的可能性（证据级别：低；推荐强度：弱推荐）
The possibility of altered pain perception in patients with OSA should be considered. (2C)
证据评价方法：GRADE
指南质量等级：B
年份：2018
国家：The Society of Anesthesia and Sleep Medicine
Array
(
[id] => 866
[catid] => 255
[title] => Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/866.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:15
[updatetime] => 2024-01-11 15:14:15
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => The Society of Anesthesia and Sleep Medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => Patients with OSA may be at increased risk for adverse respiratory events from the use of propofol for procedural sedation. (1B)
[laiyuan] => 阻塞性呼吸睡眠暂停综合征患者因使用丙泊酚进行手术镇静而使不良呼吸事件的风险发生可能增加（证据级别：中；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957255
[_updatetime] => 1704957255
[_nrjc] =>
[_nrsh] =>
)
推荐意见
阻塞性呼吸睡眠暂停综合征患者因使用丙泊酚进行手术镇静而使不良呼吸事件的风险发生可能增加（证据级别：中；推荐强度：强推荐）
Patients with OSA may be at increased risk for adverse respiratory events from the use of propofol for procedural sedation. (1B)
证据评价方法：GRADE
指南质量等级：B
年份：2018
国家：The Society of Anesthesia and Sleep Medicine
Array
(
[id] => 867
[catid] => 255
[title] => Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/867.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:15
[updatetime] => 2024-01-11 15:14:15
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2018
[guojia] => The Society of Anesthesia and Sleep Medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => There is a lack of evidence to assess residual effects of inhalational anesthetic agents in the population with OSA（Evidence level:B；Recommendation grade:No Recommendation）.
[laiyuan] => 缺乏证据来评估吸入麻醉药在阻塞性呼吸睡眠暂停综合征患者中的残留效果（证据级别：B；推荐强度：不推荐）
[znzldj] => B
[_inputtime] => 1704957255
[_updatetime] => 1704957255
[_nrjc] =>
[_nrsh] =>
)
推荐意见
缺乏证据来评估吸入麻醉药在阻塞性呼吸睡眠暂停综合征患者中的残留效果（证据级别：B；推荐强度：不推荐）
There is a lack of evidence to assess residual effects of inhalational anesthetic agents in the population with OSA（Evidence level:B；Recommendation grade:No Recommendation）.
证据评价方法：GRADE
指南质量等级：B
年份：2018
国家：The Society of Anesthesia and Sleep Medicine
Array
(
[id] => 813
[catid] => 252
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/813.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => The indications for pharmacological premedication are the same for MH-susceptible patients as those not predisposed to MH. (1C)
[laiyuan] => 对于有恶性高热易感性的患者和无恶性高热易感性的患者，药物预处理的适应症是相同的。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对于有恶性高热易感性的患者和无恶性高热易感性的患者，药物预处理的适应症是相同的。（证据级别：低；推荐强度：强推荐）
The indications for pharmacological premedication are the same for MH-susceptible patients as those not predisposed to MH. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
Array
(
[id] => 814
[catid] => 256
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/814.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => Minimum monitoring for general anaesthesia for an MHsusceptible patient is electrocardiography, pulse oximetry, noninvasive blood pressure, inspired oxygen concentration, inspired/expired CO2 with capnography, airway pressure, ventilatory frequency, minute ventilation, peripheral nerve stimulator when neuromuscular blocking agents are used, and continuous core body temperature measurement for procedures of any duration and (where available) depth of anaesthesia monitoring. (1C)
[laiyuan] => 对全身麻醉患者进行的基础监测包括心电图、脉搏血氧饱和度、无创血压、吸入氧浓度、吸入/呼出二氧化碳（带气管造影）、气道压力、通气频率、分钟通气量、使用神经肌肉阻滞剂时的外周神经刺激器、任何持续时间的连续核心体温测量以及麻醉深度监测（如有）。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对全身麻醉患者进行的基础监测包括心电图、脉搏血氧饱和度、无创血压、吸入氧浓度、吸入/呼出二氧化碳（带气管造影）、气道压力、通气频率、分钟通气量、使用神经肌肉阻滞剂时的外周神经刺激器、任何持续时间的连续核心体温测量以及麻醉深度监测（如有）。（证据级别：低；推荐强度：强推荐）
Minimum monitoring for general anaesthesia for an MHsusceptible patient is electrocardiography, pulse oximetry, noninvasive blood pressure, inspired oxygen concentration, inspired/expired CO2 with capnography, airway pressure, ventilatory frequency, minute ventilation, peripheral nerve stimulator when neuromuscular blocking agents are used, and continuous core body temperature measurement for procedures of any duration and (where available) depth of anaesthesia monitoring. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
Array
(
[id] => 815
[catid] => 256
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/815.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => If trigger-free anaesthesia is provided, an MH-susceptible patient will not need any extra monitoring during anaesthesia compared with a patient with the same condition and preoperative status, but not predisposed to MH. (1C)
[laiyuan] => 如果采用无触发麻醉，与病情和术前状态相同但无恶性高热易感性的患者相比，有恶性高热易感性的患者在麻醉期间不需要额外的监测。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果采用无触发麻醉，与病情和术前状态相同但无恶性高热易感性的患者相比，有恶性高热易感性的患者在麻醉期间不需要额外的监测。（证据级别：低；推荐强度：强推荐）
If trigger-free anaesthesia is provided, an MH-susceptible patient will not need any extra monitoring during anaesthesia compared with a patient with the same condition and preoperative status, but not predisposed to MH. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
Array
(
[id] => 816
[catid] => 264
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/816.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => MH-susceptible patients can receive standard care in the recovery room (PACU) after surgery. (1C)
[laiyuan] => 对恶性高热敏感的患者术后可在恢复室（PACU）接受标准护理。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对恶性高热敏感的患者术后可在恢复室（PACU）接受标准护理。（证据级别：低；推荐强度：强推荐）
MH-susceptible patients can receive standard care in the recovery room (PACU) after surgery. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
Array
(
[id] => 817
[catid] => 255
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/817.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => MH-susceptible patients may be anaesthetised in an outpatient setting avoiding all volatile anaesthetics and succinylcholine whilst folCing national guidelines for ambulatory general anaesthesia.. (1C).
[laiyuan] => 对恶心高热敏感的患者可在门诊进行麻醉，避免使用所有挥发性麻醉剂和琥珀胆碱，同时遵循国家门诊全身麻醉指南。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对恶心高热敏感的患者可在门诊进行麻醉，避免使用所有挥发性麻醉剂和琥珀胆碱，同时遵循国家门诊全身麻醉指南。（证据级别：低；推荐强度：强推荐）
MH-susceptible patients may be anaesthetised in an outpatient setting avoiding all volatile anaesthetics and succinylcholine whilst folCing national guidelines for ambulatory general anaesthesia.. (1C).
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
Array
(
[id] => 818
[catid] => 264
[title] => Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => /show/818.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:14:14
[updatetime] => 2024-01-11 15:14:14
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] =>
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2021
[guojia] => the European Malignant Hyperthermia Group
[pdf] =>
[tjyjyw] =>
[lyyw] => Specific pre- or postoperative blood tests are not necessary in MHsusceptible patients. (1C)
[laiyuan] => 对恶性高热易感患者无需进行特定的术前或术后血液检测。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957254
[_updatetime] => 1704957254
[_nrjc] =>
[_nrsh] =>
)
推荐意见
对恶性高热易感患者无需进行特定的术前或术后血液检测。（证据级别：低；推荐强度：强推荐）
Specific pre- or postoperative blood tests are not necessary in MHsusceptible patients. (1C)
证据评价方法：GRADE
指南质量等级：B
年份：2021
国家：the European Malignant Hyperthermia Group
